Rimantadinum 50 mg tablets
Registration number: R N002605/01
Pharmacotherapeutic group: Antiviral agent
Indications for use:
Prevention and early treatment of influenza A in adults and children over the age of 7.
50 mg tablets. 10 tablets in blister packaging.
1 or 2 blister packs with instructions for use in carton packaging.